

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hemidesmosome assembly (GO:0031581) | 7.52017965 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.91668769 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.91668769 |
| 4 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 5.69821988 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 5.63575487 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.63575487 |
| 7 | desmosome organization (GO:0002934) | 5.16467938 |
| 8 | alpha-linolenic acid metabolic process (GO:0036109) | 5.00349828 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 4.89268340 |
| 10 | response to follicle-stimulating hormone (GO:0032354) | 4.87891887 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.85092974 |
| 12 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.84254265 |
| 13 | protein carboxylation (GO:0018214) | 4.84254265 |
| 14 | negative regulation of fibrinolysis (GO:0051918) | 4.80636724 |
| 15 | cell adhesion mediated by integrin (GO:0033627) | 4.47175942 |
| 16 | glucocorticoid biosynthetic process (GO:0006704) | 4.39135401 |
| 17 | urea cycle (GO:0000050) | 4.37965638 |
| 18 | urea metabolic process (GO:0019627) | 4.37965638 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 4.37231277 |
| 20 | regulation of fibrinolysis (GO:0051917) | 4.33207405 |
| 21 | skin morphogenesis (GO:0043589) | 4.28704672 |
| 22 | bile acid biosynthetic process (GO:0006699) | 4.27352679 |
| 23 | cell-substrate junction assembly (GO:0007044) | 4.25656002 |
| 24 | complement activation, alternative pathway (GO:0006957) | 4.22047759 |
| 25 | kynurenine metabolic process (GO:0070189) | 4.16266523 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 4.16216945 |
| 27 | glyoxylate metabolic process (GO:0046487) | 4.10263211 |
| 28 | regulation of protein activation cascade (GO:2000257) | 4.09602252 |
| 29 | androgen biosynthetic process (GO:0006702) | 4.09396465 |
| 30 | tyrosine metabolic process (GO:0006570) | 4.06708325 |
| 31 | indole-containing compound catabolic process (GO:0042436) | 3.97249123 |
| 32 | indolalkylamine catabolic process (GO:0046218) | 3.97249123 |
| 33 | tryptophan catabolic process (GO:0006569) | 3.97249123 |
| 34 | nitrogen cycle metabolic process (GO:0071941) | 3.97026024 |
| 35 | negative regulation of cholesterol transport (GO:0032375) | 3.92836854 |
| 36 | negative regulation of sterol transport (GO:0032372) | 3.92836854 |
| 37 | reverse cholesterol transport (GO:0043691) | 3.88767216 |
| 38 | cysteine metabolic process (GO:0006534) | 3.86468830 |
| 39 | regulation of complement activation (GO:0030449) | 3.86096437 |
| 40 | tryptophan metabolic process (GO:0006568) | 3.86080847 |
| 41 | * plasma lipoprotein particle clearance (GO:0034381) | 3.83729311 |
| 42 | * regulation of cholesterol homeostasis (GO:2000188) | 3.81389591 |
| 43 | bile acid metabolic process (GO:0008206) | 3.81196311 |
| 44 | phospholipid efflux (GO:0033700) | 3.76644774 |
| 45 | C21-steroid hormone biosynthetic process (GO:0006700) | 3.71962557 |
| 46 | homocysteine metabolic process (GO:0050667) | 3.71663744 |
| 47 | atrioventricular valve morphogenesis (GO:0003181) | 3.69297261 |
| 48 | protein-lipid complex remodeling (GO:0034368) | 3.65336062 |
| 49 | macromolecular complex remodeling (GO:0034367) | 3.65336062 |
| 50 | plasma lipoprotein particle remodeling (GO:0034369) | 3.65336062 |
| 51 | cholesterol efflux (GO:0033344) | 3.64448635 |
| 52 | regulation of hippo signaling (GO:0035330) | 3.64426607 |
| 53 | estrogen biosynthetic process (GO:0006703) | 3.64239740 |
| 54 | endothelial cell chemotaxis (GO:0035767) | 3.63170196 |
| 55 | aromatic amino acid family metabolic process (GO:0009072) | 3.60686781 |
| 56 | cellular response to gonadotropin stimulus (GO:0071371) | 3.59005077 |
| 57 | regulation of cholesterol esterification (GO:0010872) | 3.58991766 |
| 58 | regulation of triglyceride catabolic process (GO:0010896) | 3.58903189 |
| 59 | fibrinolysis (GO:0042730) | 3.58708650 |
| 60 | cholesterol biosynthetic process (GO:0006695) | 3.55273478 |
| 61 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.53976271 |
| 62 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.53042297 |
| 63 | mesodermal cell differentiation (GO:0048333) | 3.52624020 |
| 64 | surfactant homeostasis (GO:0043129) | 3.51774052 |
| 65 | response to gonadotropin (GO:0034698) | 3.51286146 |
| 66 | triglyceride homeostasis (GO:0070328) | 3.51212643 |
| 67 | acylglycerol homeostasis (GO:0055090) | 3.51212643 |
| 68 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.49829514 |
| 69 | plasma lipoprotein particle assembly (GO:0034377) | 3.43863227 |
| 70 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.42502286 |
| 71 | cellular glucuronidation (GO:0052695) | 3.40015298 |
| 72 | bile acid and bile salt transport (GO:0015721) | 3.38929817 |
| 73 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.36928365 |
| 74 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.36842564 |
| 75 | 4-hydroxyproline metabolic process (GO:0019471) | 3.35892024 |
| 76 | glucocorticoid metabolic process (GO:0008211) | 3.35806491 |
| 77 | protein-lipid complex assembly (GO:0065005) | 3.35674772 |
| 78 | coenzyme catabolic process (GO:0009109) | 3.34822584 |
| 79 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.33443279 |
| 80 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.31701976 |
| 81 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.29208727 |
| 82 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.28474085 |
| 83 | phospholipid homeostasis (GO:0055091) | 3.28056889 |
| 84 | epithelial cell-cell adhesion (GO:0090136) | 3.27284035 |
| 85 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.25440814 |
| 86 | cellular response to antibiotic (GO:0071236) | 3.23559240 |
| 87 | * lipoprotein metabolic process (GO:0042157) | 3.23283991 |
| 88 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.23126530 |
| 89 | positive regulation of lipid catabolic process (GO:0050996) | 3.22880047 |
| 90 | serine family amino acid catabolic process (GO:0009071) | 3.22550500 |
| 91 | cellular modified amino acid catabolic process (GO:0042219) | 3.21507125 |
| 92 | glycine metabolic process (GO:0006544) | 3.20343476 |
| 93 | gap junction assembly (GO:0016264) | 3.19604923 |
| 94 | response to lipoprotein particle (GO:0055094) | 3.19389768 |
| 95 | * cholesterol homeostasis (GO:0042632) | 3.19244316 |
| 96 | negative regulation of fatty acid transport (GO:2000192) | 3.17040931 |
| 97 | * sterol homeostasis (GO:0055092) | 3.15900760 |
| 98 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.14908528 |
| 99 | sterol biosynthetic process (GO:0016126) | 3.14481580 |
| 100 | progesterone metabolic process (GO:0042448) | 3.10391000 |
| 101 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.08731228 |
| 102 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.08731228 |
| 103 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.08382729 |
| 104 | drug catabolic process (GO:0042737) | 3.08218216 |
| 105 | amino-acid betaine metabolic process (GO:0006577) | 3.07059781 |
| 106 | imidazole-containing compound metabolic process (GO:0052803) | 3.07009058 |
| 107 | alpha-amino acid catabolic process (GO:1901606) | 3.06042278 |
| 108 | blood vessel endothelial cell migration (GO:0043534) | 3.05186459 |
| 109 | regulation of cholesterol metabolic process (GO:0090181) | 3.04691787 |
| 110 | cofactor catabolic process (GO:0051187) | 3.04402533 |
| 111 | glucuronate metabolic process (GO:0019585) | 3.04327623 |
| 112 | uronic acid metabolic process (GO:0006063) | 3.04327623 |
| 113 | basement membrane organization (GO:0071711) | 3.03654402 |
| 114 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.03227399 |
| 115 | COPI coating of Golgi vesicle (GO:0048205) | 3.02736866 |
| 116 | Golgi transport vesicle coating (GO:0048200) | 3.02736866 |
| 117 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.01604179 |
| 118 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.01420067 |
| 119 | adherens junction assembly (GO:0034333) | 3.00474370 |
| 120 | acetyl-CoA metabolic process (GO:0006084) | 3.00172822 |
| 121 | Leydig cell differentiation (GO:0033327) | 2.98041750 |
| 122 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.97806932 |
| 123 | plasma lipoprotein particle organization (GO:0071827) | 2.97788693 |
| 124 | chemical homeostasis within a tissue (GO:0048875) | 2.97152255 |
| 125 | serine family amino acid biosynthetic process (GO:0009070) | 2.97147713 |
| 126 | * cholesterol metabolic process (GO:0008203) | 2.97063683 |
| 127 | semaphorin-plexin signaling pathway (GO:0071526) | 2.96248189 |
| 128 | acute-phase response (GO:0006953) | 2.96211603 |
| 129 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.96194714 |
| 130 | protein-lipid complex subunit organization (GO:0071825) | 2.96006656 |
| 131 | aldehyde catabolic process (GO:0046185) | 2.95152340 |
| 132 | serine family amino acid metabolic process (GO:0009069) | 2.93939368 |
| 133 | ethanol oxidation (GO:0006069) | 2.93931542 |
| 134 | epoxygenase P450 pathway (GO:0019373) | 2.93479405 |
| 135 | indolalkylamine metabolic process (GO:0006586) | 2.93143489 |
| 136 | regulation of plasminogen activation (GO:0010755) | 2.91220701 |
| 137 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.87841140 |
| 138 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.87190408 |
| 139 | cell-substrate adherens junction assembly (GO:0007045) | 2.87092005 |
| 140 | focal adhesion assembly (GO:0048041) | 2.87092005 |
| 141 | regulation of cholesterol storage (GO:0010885) | 2.87079731 |
| 142 | linoleic acid metabolic process (GO:0043651) | 2.86908600 |
| 143 | lysine catabolic process (GO:0006554) | 2.86606701 |
| 144 | lysine metabolic process (GO:0006553) | 2.86606701 |
| 145 | positive regulation of osteoblast proliferation (GO:0033690) | 2.86225837 |
| 146 | glutamate metabolic process (GO:0006536) | 2.86094353 |
| 147 | fatty acid elongation (GO:0030497) | 2.85151789 |
| 148 | polarized epithelial cell differentiation (GO:0030859) | 2.84220453 |
| 149 | lung vasculature development (GO:0060426) | 2.75541714 |
| 150 | endodermal cell differentiation (GO:0035987) | 2.73664546 |
| 151 | positive regulation of hormone metabolic process (GO:0032352) | 2.72632014 |
| 152 | wound healing, spreading of epidermal cells (GO:0035313) | 2.72314267 |
| 153 | protein localization to endosome (GO:0036010) | 2.71260532 |
| 154 | wound healing, spreading of cells (GO:0044319) | 2.71010401 |
| 155 | notochord development (GO:0030903) | 2.69993772 |
| 156 | hippo signaling (GO:0035329) | 2.69366000 |
| 157 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.68057315 |
| 158 | keratinocyte proliferation (GO:0043616) | 2.67099906 |
| 159 | activation of Rac GTPase activity (GO:0032863) | 2.66539677 |
| 160 | regulation of water loss via skin (GO:0033561) | 2.63466333 |
| 161 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.63445042 |
| 162 | endothelial cell morphogenesis (GO:0001886) | 2.63239151 |
| 163 | C21-steroid hormone metabolic process (GO:0008207) | 2.55986688 |
| 164 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.54047899 |
| 165 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.53999490 |
| 166 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.51726164 |
| 167 | trophoblast giant cell differentiation (GO:0060707) | 2.46764948 |
| 168 | mammary gland development (GO:0030879) | 2.45455028 |
| 169 | substrate-dependent cell migration (GO:0006929) | 2.45334823 |
| 170 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.44149869 |
| 171 | neural crest cell development (GO:0014032) | 2.37010279 |
| 172 | positive regulation of p38MAPK cascade (GO:1900745) | 2.36401698 |
| 173 | regulation of establishment of planar polarity (GO:0090175) | 2.34483075 |
| 174 | glomerular visceral epithelial cell development (GO:0072015) | 2.34177747 |
| 175 | ER overload response (GO:0006983) | 2.33969535 |
| 176 | adhesion of symbiont to host (GO:0044406) | 2.33462210 |
| 177 | cell junction assembly (GO:0034329) | 2.31894294 |
| 178 | * low-density lipoprotein particle clearance (GO:0034383) | 2.31681497 |
| 179 | positive regulation of male gonad development (GO:2000020) | 2.31321748 |
| 180 | chondrocyte proliferation (GO:0035988) | 2.30809633 |
| 181 | COPII vesicle coating (GO:0048208) | 2.30018129 |
| 182 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.28343203 |
| 183 | mating behavior (GO:0007617) | 2.27245077 |
| 184 | * sterol metabolic process (GO:0016125) | 2.26278778 |
| 185 | hormone biosynthetic process (GO:0042446) | 2.26254739 |
| 186 | establishment of skin barrier (GO:0061436) | 2.26070508 |
| 187 | negative regulation of catenin import into nucleus (GO:0035414) | 2.24182815 |
| 188 | nuclear envelope reassembly (GO:0031468) | 2.23865427 |
| 189 | mitotic nuclear envelope reassembly (GO:0007084) | 2.23865427 |
| 190 | smooth muscle tissue development (GO:0048745) | 2.23824850 |
| 191 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.21756702 |
| 192 | cellular response to toxic substance (GO:0097237) | 2.20788357 |
| 193 | negative regulation of cartilage development (GO:0061037) | 2.20249489 |
| 194 | placenta blood vessel development (GO:0060674) | 2.19985876 |
| 195 | facial nerve structural organization (GO:0021612) | 2.19950492 |
| 196 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.19078134 |
| 197 | regulation of G0 to G1 transition (GO:0070316) | 2.18822897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.24128151 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.92145630 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.23537958 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.83807832 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.46034296 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.14637626 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.51174155 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.35421648 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.32995602 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.99911600 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.60300613 |
| 12 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.51774600 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.42317196 |
| 14 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.37051607 |
| 15 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.36958823 |
| 16 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.36075558 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.21479489 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.03612486 |
| 19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.99808180 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.95347561 |
| 21 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.77783784 |
| 22 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.73838237 |
| 23 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.72360933 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.72133728 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.64839861 |
| 26 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64537321 |
| 27 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.63148668 |
| 28 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.61619826 |
| 29 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.56973024 |
| 30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.54754340 |
| 31 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.54670683 |
| 32 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.54198834 |
| 33 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.53915360 |
| 34 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.51276873 |
| 35 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.48881678 |
| 36 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.48769162 |
| 37 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.48004767 |
| 38 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.47498950 |
| 39 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.47416719 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.46267106 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45826794 |
| 42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.43537358 |
| 43 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.41576147 |
| 44 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.41176418 |
| 45 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.39717240 |
| 46 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.39318930 |
| 47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.38098681 |
| 48 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.37774381 |
| 49 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36694672 |
| 50 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.33587221 |
| 51 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.33313014 |
| 52 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.32172614 |
| 53 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.28526785 |
| 54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28402825 |
| 55 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.27200950 |
| 56 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26376499 |
| 57 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24341061 |
| 58 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.23759581 |
| 59 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21574278 |
| 60 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20946531 |
| 61 | KDM2B_26808549_Chip-Seq_K562_Human | 1.20675480 |
| 62 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20574792 |
| 63 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.19405000 |
| 64 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19053052 |
| 65 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.18695515 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17990820 |
| 67 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.17253899 |
| 68 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15774717 |
| 69 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.14243624 |
| 70 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.13455262 |
| 71 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.12894677 |
| 72 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.12213645 |
| 73 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.11307764 |
| 74 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10648917 |
| 75 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.09392743 |
| 76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.08865552 |
| 77 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08449177 |
| 78 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.07826943 |
| 79 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.07769249 |
| 80 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.07215964 |
| 81 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.07051707 |
| 82 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06000436 |
| 83 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05945056 |
| 84 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05734707 |
| 85 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.04942666 |
| 86 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.03855418 |
| 87 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02217006 |
| 88 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.01055499 |
| 89 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.00819463 |
| 90 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.00819463 |
| 91 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.00282863 |
| 92 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.99610261 |
| 93 | * FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.98500135 |
| 94 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.98071536 |
| 95 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97514593 |
| 96 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.97010172 |
| 97 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.96499603 |
| 98 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.96400452 |
| 99 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.95172336 |
| 100 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.94561980 |
| 101 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.94146733 |
| 102 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.93893885 |
| 103 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.93498240 |
| 104 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.93310925 |
| 105 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.92967256 |
| 106 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92133319 |
| 107 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90717872 |
| 108 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.90488407 |
| 109 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89673532 |
| 110 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.88790140 |
| 111 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.88790140 |
| 112 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.87138090 |
| 113 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.86685527 |
| 114 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.85204084 |
| 115 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85066919 |
| 116 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85066919 |
| 117 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.84245295 |
| 118 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.81544544 |
| 119 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.81408632 |
| 120 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.81116047 |
| 121 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80307075 |
| 122 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.80211916 |
| 123 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.79499361 |
| 124 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79398670 |
| 125 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.79187792 |
| 126 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78083528 |
| 127 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.76676307 |
| 128 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.76398710 |
| 129 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74582082 |
| 130 | GATA2_19941826_ChIP-Seq_K562_Human | 0.74115494 |
| 131 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.73424575 |
| 132 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72786713 |
| 133 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.72456608 |
| 134 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.71078226 |
| 135 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.70682707 |
| 136 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.70532111 |
| 137 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.70208456 |
| 138 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.69340747 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.39720854 |
| 2 | MP0005360_urolithiasis | 5.41200402 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.61463551 |
| 4 | MP0005365_abnormal_bile_salt | 4.41901095 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.52341025 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.36298709 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.36204602 |
| 8 | MP0003252_abnormal_bile_duct | 3.24658680 |
| 9 | MP0003950_abnormal_plasma_membrane | 2.89405448 |
| 10 | * MP0009840_abnormal_foam_cell | 2.78595358 |
| 11 | MP0003195_calcinosis | 2.65051507 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.64583155 |
| 13 | MP0003941_abnormal_skin_development | 2.62820924 |
| 14 | MP0010030_abnormal_orbit_morphology | 2.34957350 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 2.23747367 |
| 16 | MP0000537_abnormal_urethra_morphology | 2.10984723 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.10495904 |
| 18 | MP0000566_synostosis | 2.08509652 |
| 19 | MP0000762_abnormal_tongue_morphology | 2.06503907 |
| 20 | * MP0005083_abnormal_biliary_tract | 2.02202920 |
| 21 | MP0005409_darkened_coat_color | 2.01504515 |
| 22 | MP0002877_abnormal_melanocyte_morpholog | 1.99208735 |
| 23 | * MP0000609_abnormal_liver_physiology | 1.84454629 |
| 24 | MP0003300_gastrointestinal_ulcer | 1.80033204 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.79840208 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.77156640 |
| 27 | * MP0002118_abnormal_lipid_homeostasis | 1.71173386 |
| 28 | MP0003566_abnormal_cell_adhesion | 1.63659950 |
| 29 | MP0004782_abnormal_surfactant_physiolog | 1.62295784 |
| 30 | MP0000383_abnormal_hair_follicle | 1.61863681 |
| 31 | MP0003868_abnormal_feces_composition | 1.56494866 |
| 32 | * MP0005332_abnormal_amino_acid | 1.56116697 |
| 33 | MP0002089_abnormal_postnatal_growth/wei | 1.52284964 |
| 34 | MP0002254_reproductive_system_inflammat | 1.49875072 |
| 35 | MP0004233_abnormal_muscle_weight | 1.49260518 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.48102328 |
| 37 | MP0005408_hypopigmentation | 1.44331513 |
| 38 | MP0005275_abnormal_skin_tensile | 1.43182372 |
| 39 | MP0002098_abnormal_vibrissa_morphology | 1.42517328 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.42227555 |
| 41 | MP0000678_abnormal_parathyroid_gland | 1.41767929 |
| 42 | MP0005257_abnormal_intraocular_pressure | 1.37232180 |
| 43 | MP0003315_abnormal_perineum_morphology | 1.36908839 |
| 44 | MP0010234_abnormal_vibrissa_follicle | 1.33678470 |
| 45 | MP0005623_abnormal_meninges_morphology | 1.33651300 |
| 46 | MP0005319_abnormal_enzyme/_coenzyme | 1.29299360 |
| 47 | MP0010771_integument_phenotype | 1.27507189 |
| 48 | MP0003453_abnormal_keratinocyte_physiol | 1.26335627 |
| 49 | MP0005023_abnormal_wound_healing | 1.24433555 |
| 50 | MP0004019_abnormal_vitamin_homeostasis | 1.23384360 |
| 51 | MP0003436_decreased_susceptibility_to | 1.22272165 |
| 52 | MP0000534_abnormal_ureter_morphology | 1.19161429 |
| 53 | MP0002060_abnormal_skin_morphology | 1.17842565 |
| 54 | MP0003755_abnormal_palate_morphology | 1.17464866 |
| 55 | MP0005508_abnormal_skeleton_morphology | 1.15263345 |
| 56 | MP0009643_abnormal_urine_homeostasis | 1.14965749 |
| 57 | * MP0000598_abnormal_liver_morphology | 1.13576792 |
| 58 | MP0002796_impaired_skin_barrier | 1.08238594 |
| 59 | MP0003283_abnormal_digestive_organ | 1.05577734 |
| 60 | MP0005076_abnormal_cell_differentiation | 1.05521221 |
| 61 | MP0001879_abnormal_lymphatic_vessel | 1.05509744 |
| 62 | MP0005220_abnormal_exocrine_pancreas | 1.05433911 |
| 63 | MP0002086_abnormal_extraembryonic_tissu | 1.01690550 |
| 64 | * MP0004947_skin_inflammation | 1.00837650 |
| 65 | MP0004264_abnormal_extraembryonic_tissu | 0.99875047 |
| 66 | MP0001958_emphysema | 0.96106128 |
| 67 | MP0005451_abnormal_body_composition | 0.95768269 |
| 68 | MP0004858_abnormal_nervous_system | 0.95703920 |
| 69 | MP0002697_abnormal_eye_size | 0.95503736 |
| 70 | MP0002282_abnormal_trachea_morphology | 0.95437782 |
| 71 | MP0003937_abnormal_limbs/digits/tail_de | 0.94465521 |
| 72 | MP0003303_peritoneal_inflammation | 0.94357742 |
| 73 | MP0002111_abnormal_tail_morphology | 0.94247892 |
| 74 | MP0003115_abnormal_respiratory_system | 0.93898626 |
| 75 | MP0003984_embryonic_growth_retardation | 0.93686740 |
| 76 | MP0000767_abnormal_smooth_muscle | 0.93393223 |
| 77 | MP0001299_abnormal_eye_distance/ | 0.92830101 |
| 78 | MP0009763_increased_sensitivity_to | 0.91168485 |
| 79 | MP0002088_abnormal_embryonic_growth/wei | 0.91118201 |
| 80 | MP0000013_abnormal_adipose_tissue | 0.90631542 |
| 81 | MP0008007_abnormal_cellular_replicative | 0.90383433 |
| 82 | MP0002925_abnormal_cardiovascular_devel | 0.90284138 |
| 83 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89730368 |
| 84 | MP0003942_abnormal_urinary_system | 0.89021065 |
| 85 | MP0009053_abnormal_anal_canal | 0.88788341 |
| 86 | * MP0001243_abnormal_dermal_layer | 0.86737043 |
| 87 | MP0005380_embryogenesis_phenotype | 0.86560102 |
| 88 | MP0001672_abnormal_embryogenesis/_devel | 0.86560102 |
| 89 | MP0004197_abnormal_fetal_growth/weight/ | 0.86332051 |
| 90 | MP0003935_abnormal_craniofacial_develop | 0.85508959 |
| 91 | MP0004272_abnormal_basement_membrane | 0.85494991 |
| 92 | * MP0009931_abnormal_skin_appearance | 0.84616957 |
| 93 | MP0003091_abnormal_cell_migration | 0.84608564 |
| 94 | MP0003172_abnormal_lysosome_physiology | 0.84484690 |
| 95 | MP0005621_abnormal_cell_physiology | 0.82435040 |
| 96 | MP0003693_abnormal_embryo_hatching | 0.82386310 |
| 97 | * MP0005197_abnormal_uvea_morphology | 0.82001732 |
| 98 | MP0009384_cardiac_valve_regurgitation | 0.81885907 |
| 99 | MP0004185_abnormal_adipocyte_glucose | 0.81617230 |
| 100 | MP0000627_abnormal_mammary_gland | 0.81186930 |
| 101 | MP0000432_abnormal_head_morphology | 0.80962833 |
| 102 | MP0000751_myopathy | 0.80857343 |
| 103 | MP0002896_abnormal_bone_mineralization | 0.80319790 |
| 104 | MP0008932_abnormal_embryonic_tissue | 0.80216663 |
| 105 | MP0002084_abnormal_developmental_patter | 0.80194372 |
| 106 | MP0005464_abnormal_platelet_physiology | 0.79928990 |
| 107 | MP0003943_abnormal_hepatobiliary_system | 0.78991674 |
| 108 | MP0001533_abnormal_skeleton_physiology | 0.78952426 |
| 109 | MP0003385_abnormal_body_wall | 0.77993344 |
| 110 | MP0001348_abnormal_lacrimal_gland | 0.76688159 |
| 111 | MP0001849_ear_inflammation | 0.76416370 |
| 112 | MP0002168_other_aberrant_phenotype | 0.75646663 |
| 113 | * MP0001614_abnormal_blood_vessel | 0.74678012 |
| 114 | * MP0008469_abnormal_protein_level | 0.74314083 |
| 115 | MP0006138_congestive_heart_failure | 0.74125320 |
| 116 | MP0002234_abnormal_pharynx_morphology | 0.73915681 |
| 117 | * MP0000604_amyloidosis | 0.73573895 |
| 118 | MP0009780_abnormal_chondrocyte_physiolo | 0.73250611 |
| 119 | MP0000733_abnormal_muscle_development | 0.73125596 |
| 120 | MP0001944_abnormal_pancreas_morphology | 0.73123496 |
| 121 | MP0000538_abnormal_urinary_bladder | 0.72606589 |
| 122 | MP0003786_premature_aging | 0.72420027 |
| 123 | MP0002909_abnormal_adrenal_gland | 0.72328090 |
| 124 | MP0000428_abnormal_craniofacial_morphol | 0.71946788 |
| 125 | MP0000462_abnormal_digestive_system | 0.71864153 |
| 126 | MP0002085_abnormal_embryonic_tissue | 0.71838676 |
| 127 | MP0002295_abnormal_pulmonary_circulatio | 0.71508569 |
| 128 | * MP0002078_abnormal_glucose_homeostasis | 0.71230663 |
| 129 | MP0003656_abnormal_erythrocyte_physiolo | 0.71169505 |
| 130 | * MP0002080_prenatal_lethality | 0.70986017 |
| 131 | MP0003186_abnormal_redox_activity | 0.68958840 |
| 132 | MP0001216_abnormal_epidermal_layer | 0.68551076 |
| 133 | MP0006082_CNS_inflammation | 0.66645197 |
| 134 | MP0003279_aneurysm | 0.65238516 |
| 135 | * MP0009642_abnormal_blood_homeostasis | 0.63757816 |
| 136 | MP0003045_fibrosis | 0.63204417 |
| 137 | MP0010678_abnormal_skin_adnexa | 0.63070906 |
| 138 | MP0000467_abnormal_esophagus_morphology | 0.61972728 |
| 139 | MP0010368_abnormal_lymphatic_system | 0.61746338 |
| 140 | MP0002928_abnormal_bile_duct | 0.61113169 |
| 141 | MP0002693_abnormal_pancreas_physiology | 0.60584516 |
| 142 | MP0003690_abnormal_glial_cell | 0.59667830 |
| 143 | MP0001881_abnormal_mammary_gland | 0.58927384 |
| 144 | MP0001661_extended_life_span | 0.58785392 |
| 145 | MP0001756_abnormal_urination | 0.58369984 |
| 146 | MP0009764_decreased_sensitivity_to | 0.58186693 |
| 147 | MP0003075_altered_response_to | 0.58138673 |
| 148 | MP0006054_spinal_hemorrhage | 0.57403600 |
| 149 | MP0000377_abnormal_hair_follicle | 0.57366070 |
| 150 | MP0001764_abnormal_homeostasis | 0.57317399 |
| 151 | MP0000579_abnormal_nail_morphology | 0.56867157 |
| 152 | MP0009672_abnormal_birth_weight | 0.56183977 |
| 153 | MP0005501_abnormal_skin_physiology | 0.55666918 |
| 154 | MP0005164_abnormal_response_to | 0.54374624 |
| 155 | MP0003724_increased_susceptibility_to | 0.53498527 |
| 156 | MP0009765_abnormal_xenobiotic_induced | 0.52701004 |
| 157 | MP0000003_abnormal_adipose_tissue | 0.52542732 |
| 158 | MP0005248_abnormal_Harderian_gland | 0.52035426 |
| 159 | MP0001915_intracranial_hemorrhage | 0.50912855 |
| 160 | MP0005375_adipose_tissue_phenotype | 0.49013658 |
| 161 | MP0002933_joint_inflammation | 0.48108026 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.10162449 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.96790489 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.69215550 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.37791959 |
| 5 | * Xanthomatosis (HP:0000991) | 4.88587238 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 4.43717781 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.42015913 |
| 8 | Atrophic scars (HP:0001075) | 4.04095219 |
| 9 | Abnormality of the common coagulation pathway (HP:0010990) | 3.94567695 |
| 10 | Milia (HP:0001056) | 3.84521554 |
| 11 | Hypoglycemic coma (HP:0001325) | 3.82836162 |
| 12 | Complement deficiency (HP:0004431) | 3.76170047 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 3.72409439 |
| 14 | Hypolipoproteinemia (HP:0010981) | 3.48151881 |
| 15 | Joint hemorrhage (HP:0005261) | 3.47778972 |
| 16 | Short nail (HP:0001799) | 3.37608168 |
| 17 | Myocardial infarction (HP:0001658) | 3.35553583 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.33157532 |
| 19 | Peritonitis (HP:0002586) | 3.30083749 |
| 20 | Hypoglycemic seizures (HP:0002173) | 3.29293351 |
| 21 | Fragile nails (HP:0001808) | 3.28587862 |
| 22 | Fat malabsorption (HP:0002630) | 3.25162439 |
| 23 | Abnormality of the intrinsic pathway (HP:0010989) | 3.23309795 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.20666128 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.17466702 |
| 26 | Onycholysis (HP:0001806) | 3.16923329 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.16538105 |
| 28 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.14265602 |
| 29 | Abnormality of complement system (HP:0005339) | 3.07704471 |
| 30 | Fragile skin (HP:0001030) | 3.02483632 |
| 31 | Broad face (HP:0000283) | 3.00529006 |
| 32 | Thick nail (HP:0001805) | 2.99980904 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 2.93661324 |
| 34 | Natal tooth (HP:0000695) | 2.92513828 |
| 35 | Alopecia of scalp (HP:0002293) | 2.91220713 |
| 36 | Hypercholesterolemia (HP:0003124) | 2.88840476 |
| 37 | Plantar hyperkeratosis (HP:0007556) | 2.85464939 |
| 38 | Abnormality of methionine metabolism (HP:0010901) | 2.84741401 |
| 39 | Bronchomalacia (HP:0002780) | 2.82994158 |
| 40 | Ketosis (HP:0001946) | 2.82864189 |
| 41 | Abnormality of nail color (HP:0100643) | 2.76710812 |
| 42 | Arterial tortuosity (HP:0005116) | 2.75948321 |
| 43 | Premature rupture of membranes (HP:0001788) | 2.67806334 |
| 44 | Hyperammonemia (HP:0001987) | 2.64772798 |
| 45 | Turricephaly (HP:0000262) | 2.63791126 |
| 46 | * Epidermoid cyst (HP:0200040) | 2.62474463 |
| 47 | Shallow orbits (HP:0000586) | 2.61908412 |
| 48 | Pterygium (HP:0001059) | 2.61495120 |
| 49 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.59231812 |
| 50 | Esophageal varix (HP:0002040) | 2.56552244 |
| 51 | Vascular tortuosity (HP:0004948) | 2.51475005 |
| 52 | Advanced eruption of teeth (HP:0006288) | 2.48211896 |
| 53 | Breast hypoplasia (HP:0003187) | 2.47092215 |
| 54 | Spastic diplegia (HP:0001264) | 2.46877389 |
| 55 | Mitral stenosis (HP:0001718) | 2.42456447 |
| 56 | Right ventricular cardiomyopathy (HP:0011663) | 2.39349868 |
| 57 | Nail dystrophy (HP:0008404) | 2.39241503 |
| 58 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.39074876 |
| 59 | Symptomatic seizures (HP:0011145) | 2.38553108 |
| 60 | Increased mean platelet volume (HP:0011877) | 2.38340154 |
| 61 | Hepatocellular carcinoma (HP:0001402) | 2.36151555 |
| 62 | Abnormality of the nasal septum (HP:0000419) | 2.33153995 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 2.33050155 |
| 64 | Hypoplasia of dental enamel (HP:0006297) | 2.30483948 |
| 65 | Ketoacidosis (HP:0001993) | 2.29247441 |
| 66 | Hyperacusis (HP:0010780) | 2.26755486 |
| 67 | Protrusio acetabuli (HP:0003179) | 2.25491458 |
| 68 | Steatorrhea (HP:0002570) | 2.25220718 |
| 69 | Abnormality of carpal bone ossification (HP:0006257) | 2.22925245 |
| 70 | 11 pairs of ribs (HP:0000878) | 2.22758646 |
| 71 | Hyperglycemia (HP:0003074) | 2.21822716 |
| 72 | Hyperglycinemia (HP:0002154) | 2.21224704 |
| 73 | Bowing of the arm (HP:0006488) | 2.20467577 |
| 74 | Bowed forearm bones (HP:0003956) | 2.20467577 |
| 75 | Popliteal pterygium (HP:0009756) | 2.19722909 |
| 76 | Renal salt wasting (HP:0000127) | 2.19399588 |
| 77 | Selective tooth agenesis (HP:0001592) | 2.19220456 |
| 78 | Abnormality of nucleobase metabolism (HP:0010932) | 2.19049877 |
| 79 | * Skin nodule (HP:0200036) | 2.19004652 |
| 80 | Deviation of the thumb (HP:0009603) | 2.18507017 |
| 81 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.16497073 |
| 82 | Late onset (HP:0003584) | 2.16360986 |
| 83 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.16148125 |
| 84 | Menorrhagia (HP:0000132) | 2.15965848 |
| 85 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.14058215 |
| 86 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.14058215 |
| 87 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.13774626 |
| 88 | Bladder diverticulum (HP:0000015) | 2.12547480 |
| 89 | Protuberant abdomen (HP:0001538) | 2.11906552 |
| 90 | Amyloidosis (HP:0011034) | 2.11088166 |
| 91 | Axonal loss (HP:0003447) | 2.10958308 |
| 92 | Hyperbilirubinemia (HP:0002904) | 2.10061678 |
| 93 | Abnormality of purine metabolism (HP:0004352) | 2.09037377 |
| 94 | Abnormal ossification of hand bones (HP:0005921) | 2.08780230 |
| 95 | Abnormality of glycine metabolism (HP:0010895) | 2.08731974 |
| 96 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.08731974 |
| 97 | Abnormal cartilage morphology (HP:0002763) | 2.07803945 |
| 98 | Hemorrhage of the eye (HP:0011885) | 2.06402866 |
| 99 | Coronal craniosynostosis (HP:0004440) | 2.06354365 |
| 100 | Elevated alkaline phosphatase (HP:0003155) | 2.06343842 |
| 101 | Abnormal platelet volume (HP:0011876) | 2.04316885 |
| 102 | Back pain (HP:0003418) | 2.03279499 |
| 103 | Ridged nail (HP:0001807) | 2.00485544 |
| 104 | Ankyloglossia (HP:0010296) | 2.00438399 |
| 105 | Ureteral duplication (HP:0000073) | 2.00413058 |
| 106 | Palmoplantar hyperkeratosis (HP:0000972) | 2.00303962 |
| 107 | Abnormality of proline metabolism (HP:0010907) | 1.98710842 |
| 108 | Hydroxyprolinuria (HP:0003080) | 1.98710842 |
| 109 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.98000212 |
| 110 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.97582262 |
| 111 | Mucopolysacchariduria (HP:0008155) | 1.97582262 |
| 112 | Ankle contracture (HP:0006466) | 1.97315682 |
| 113 | Cerebral inclusion bodies (HP:0100314) | 1.97304379 |
| 114 | Acanthocytosis (HP:0001927) | 1.97176557 |
| 115 | Abdominal distention (HP:0003270) | 1.96940854 |
| 116 | Gingival bleeding (HP:0000225) | 1.96767472 |
| 117 | Disproportionate tall stature (HP:0001519) | 1.96507892 |
| 118 | Glomerulonephritis (HP:0000099) | 1.95146977 |
| 119 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.94891192 |
| 120 | Ulnar bowing (HP:0003031) | 1.94546291 |
| 121 | Facial hemangioma (HP:0000329) | 1.94243633 |
| 122 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.92799271 |
| 123 | Cardiovascular calcification (HP:0011915) | 1.92288674 |
| 124 | Wormian bones (HP:0002645) | 1.91954785 |
| 125 | Spinal rigidity (HP:0003306) | 1.91596984 |
| 126 | Peripheral demyelination (HP:0011096) | 1.90409229 |
| 127 | Abnormal gallbladder morphology (HP:0012437) | 1.89699600 |
| 128 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.89392902 |
| 129 | Vascular calcification (HP:0004934) | 1.88837332 |
| 130 | Neurofibrillary tangles (HP:0002185) | 1.88393714 |
| 131 | Tibial bowing (HP:0002982) | 1.87958042 |
| 132 | Irritability (HP:0000737) | 1.87637681 |
| 133 | Follicular hyperkeratosis (HP:0007502) | 1.87207314 |
| 134 | Capillary hemangiomas (HP:0005306) | 1.86684128 |
| 135 | Neonatal short-limb short stature (HP:0008921) | 1.85964219 |
| 136 | Increased number of teeth (HP:0011069) | 1.85023280 |
| 137 | Palmar hyperkeratosis (HP:0010765) | 1.84883905 |
| 138 | Abnormality of oral frenula (HP:0000190) | 1.84098782 |
| 139 | Absent eyelashes (HP:0000561) | 1.82733652 |
| 140 | Vertebral hypoplasia (HP:0008417) | 1.81627741 |
| 141 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.81627741 |
| 142 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.80932919 |
| 143 | Pseudobulbar signs (HP:0002200) | 1.80585522 |
| 144 | Septate vagina (HP:0001153) | 1.80528746 |
| 145 | Heterotopia (HP:0002282) | 1.80481209 |
| 146 | Abnormality of the Achilles tendon (HP:0005109) | 1.79234313 |
| 147 | Short humerus (HP:0005792) | 1.79010112 |
| 148 | Aortic dissection (HP:0002647) | 1.78936363 |
| 149 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.77921519 |
| 150 | Osteolytic defects of the hand bones (HP:0009699) | 1.77921519 |
| 151 | Hyperglycinuria (HP:0003108) | 1.77488222 |
| 152 | Abnormality of iron homeostasis (HP:0011031) | 1.77376832 |
| 153 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.76817932 |
| 154 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.76817932 |
| 155 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.76817932 |
| 156 | Cervical subluxation (HP:0003308) | 1.76610049 |
| 157 | Ectopia lentis (HP:0001083) | 1.75939266 |
| 158 | Vertebral clefting (HP:0008428) | 1.74524202 |
| 159 | Flat acetabular roof (HP:0003180) | 1.73141365 |
| 160 | Tracheal stenosis (HP:0002777) | 1.72836096 |
| 161 | Vertebral arch anomaly (HP:0008438) | 1.71978230 |
| 162 | Nephritis (HP:0000123) | 1.71584560 |
| 163 | Interstitial pulmonary disease (HP:0006530) | 1.70260139 |
| 164 | Aplasia of the phalanges of the hand (HP:0009802) | 1.69730240 |
| 165 | Aplasia involving bones of the extremities (HP:0009825) | 1.69730240 |
| 166 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.69730240 |
| 167 | Thin bony cortex (HP:0002753) | 1.69611821 |
| 168 | Cerebral aneurysm (HP:0004944) | 1.69609849 |
| 169 | Morphological abnormality of the middle ear (HP:0008609) | 1.67198463 |
| 170 | Lip pit (HP:0100267) | 1.66725009 |
| 171 | Focal segmental glomerulosclerosis (HP:0000097) | 1.66569079 |
| 172 | Proximal placement of thumb (HP:0009623) | 1.64273535 |
| 173 | Blue sclerae (HP:0000592) | 1.63513706 |
| 174 | Abnormal hand bone ossification (HP:0010660) | 1.63136216 |
| 175 | Elbow flexion contracture (HP:0002987) | 1.60641036 |
| 176 | Long palpebral fissure (HP:0000637) | 1.60330989 |
| 177 | Soft skin (HP:0000977) | 1.59085669 |
| 178 | Aortic aneurysm (HP:0004942) | 1.58958990 |
| 179 | Entropion (HP:0000621) | 1.58603918 |
| 180 | Difficulty climbing stairs (HP:0003551) | 1.57126496 |
| 181 | Oligodontia (HP:0000677) | 1.55813886 |
| 182 | Missing ribs (HP:0000921) | 1.55293201 |
| 183 | Laryngomalacia (HP:0001601) | 1.55072356 |
| 184 | Trismus (HP:0000211) | 1.54698554 |
| 185 | Distal lower limb amyotrophy (HP:0008944) | 1.54206292 |
| 186 | Upper limb muscle weakness (HP:0003484) | 1.53438127 |
| 187 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.53104283 |
| 188 | Poikiloderma (HP:0001029) | 1.53030256 |
| 189 | Overlapping toe (HP:0001845) | 1.51334288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.73766794 |
| 2 | SIK1 | 3.38007504 |
| 3 | TRIB3 | 3.36227302 |
| 4 | PKN2 | 2.85894542 |
| 5 | EPHB1 | 2.70024473 |
| 6 | FGFR4 | 2.56327547 |
| 7 | MET | 2.54268900 |
| 8 | EPHA2 | 2.36535877 |
| 9 | INSRR | 2.30064109 |
| 10 | PTK6 | 2.26889429 |
| 11 | MST1R | 2.15199712 |
| 12 | FLT3 | 2.15087122 |
| 13 | TAOK3 | 2.12215864 |
| 14 | LMTK2 | 2.10257200 |
| 15 | PIM2 | 1.97984344 |
| 16 | BMX | 1.91195082 |
| 17 | LATS1 | 1.88664660 |
| 18 | LATS2 | 1.85130468 |
| 19 | PTK2 | 1.83042477 |
| 20 | TSSK6 | 1.79009030 |
| 21 | PDGFRA | 1.73812303 |
| 22 | SMG1 | 1.66361401 |
| 23 | ERBB4 | 1.62127024 |
| 24 | MAP3K10 | 1.61347394 |
| 25 | EPHA3 | 1.58184147 |
| 26 | RIPK1 | 1.41198322 |
| 27 | TTN | 1.40882991 |
| 28 | TYK2 | 1.40561485 |
| 29 | AKT3 | 1.39983173 |
| 30 | MAP3K2 | 1.39431469 |
| 31 | NTRK1 | 1.32283475 |
| 32 | EEF2K | 1.32135240 |
| 33 | BCKDK | 1.30135580 |
| 34 | CAMK1D | 1.29474805 |
| 35 | DDR2 | 1.28142223 |
| 36 | TBK1 | 1.26883078 |
| 37 | PASK | 1.26753639 |
| 38 | FRK | 1.24605204 |
| 39 | LRRK2 | 1.21215380 |
| 40 | MAPK15 | 1.20033789 |
| 41 | CDK12 | 1.19294461 |
| 42 | MAP2K2 | 1.16673093 |
| 43 | MAP3K3 | 1.11617562 |
| 44 | SCYL2 | 1.11188410 |
| 45 | MTOR | 1.08054672 |
| 46 | FGFR2 | 1.06718104 |
| 47 | BRSK2 | 1.05221983 |
| 48 | JAK1 | 1.04307854 |
| 49 | MELK | 0.97656625 |
| 50 | MAP3K9 | 0.95430394 |
| 51 | PDGFRB | 0.94114016 |
| 52 | ICK | 0.94084807 |
| 53 | PIK3CG | 0.93711518 |
| 54 | MAP3K14 | 0.92787080 |
| 55 | WEE1 | 0.91170358 |
| 56 | CSK | 0.88982266 |
| 57 | MAP3K1 | 0.88408467 |
| 58 | RET | 0.88376977 |
| 59 | STK10 | 0.87715799 |
| 60 | PAK2 | 0.87455671 |
| 61 | WNK4 | 0.87094030 |
| 62 | JAK2 | 0.86525447 |
| 63 | JAK3 | 0.86274156 |
| 64 | NEK2 | 0.83130343 |
| 65 | GSK3A | 0.81731165 |
| 66 | DYRK1B | 0.81658914 |
| 67 | CDK6 | 0.79733110 |
| 68 | NEK9 | 0.79448886 |
| 69 | CAMK1G | 0.79043802 |
| 70 | CHUK | 0.77556073 |
| 71 | STK3 | 0.77199501 |
| 72 | RPS6KA2 | 0.76453180 |
| 73 | CDK7 | 0.74537949 |
| 74 | PBK | 0.73886104 |
| 75 | ERBB2 | 0.73845698 |
| 76 | CDK8 | 0.71705326 |
| 77 | KSR2 | 0.71236195 |
| 78 | FER | 0.70247085 |
| 79 | ABL2 | 0.69385971 |
| 80 | PAK3 | 0.68816012 |
| 81 | FGFR1 | 0.68549138 |
| 82 | TRPM7 | 0.68470892 |
| 83 | HIPK2 | 0.68030851 |
| 84 | TESK2 | 0.65319366 |
| 85 | MAP2K1 | 0.64458539 |
| 86 | PRKD2 | 0.63472487 |
| 87 | TGFBR1 | 0.62646040 |
| 88 | MAP3K8 | 0.62625765 |
| 89 | MAP2K3 | 0.60925621 |
| 90 | FGFR3 | 0.60326228 |
| 91 | TGFBR2 | 0.59963763 |
| 92 | PDK2 | 0.59856109 |
| 93 | MAPK11 | 0.58380861 |
| 94 | CLK1 | 0.58173736 |
| 95 | PNCK | 0.58124994 |
| 96 | TTK | 0.57678396 |
| 97 | CDC42BPA | 0.57073502 |
| 98 | MAP3K6 | 0.56816779 |
| 99 | PRKG2 | 0.56135541 |
| 100 | IKBKB | 0.55435730 |
| 101 | ALK | 0.54797304 |
| 102 | EGFR | 0.53700871 |
| 103 | STK38 | 0.53325493 |
| 104 | BLK | 0.52881348 |
| 105 | MOS | 0.50461849 |
| 106 | PAK4 | 0.50360507 |
| 107 | BRD4 | 0.49895215 |
| 108 | RAF1 | 0.49658627 |
| 109 | PRKAA2 | 0.47092374 |
| 110 | ZAP70 | 0.45734092 |
| 111 | TESK1 | 0.44989838 |
| 112 | FGR | 0.44614097 |
| 113 | PRKCI | 0.44291519 |
| 114 | WNK1 | 0.43834112 |
| 115 | CSF1R | 0.43216650 |
| 116 | TAOK2 | 0.42549144 |
| 117 | INSR | 0.42251487 |
| 118 | IRAK3 | 0.41977572 |
| 119 | AURKA | 0.40971026 |
| 120 | RPS6KB2 | 0.40656073 |
| 121 | DMPK | 0.40164501 |
| 122 | BRSK1 | 0.38543915 |
| 123 | IGF1R | 0.38459529 |
| 124 | EPHB2 | 0.37392646 |
| 125 | CHEK2 | 0.36899631 |
| 126 | MAP3K7 | 0.35661911 |
| 127 | PRKD1 | 0.35416404 |
| 128 | PRPF4B | 0.34798757 |
| 129 | ABL1 | 0.34257127 |
| 130 | MATK | 0.34109573 |
| 131 | MAPKAPK3 | 0.33957919 |
| 132 | RPS6KA1 | 0.33711665 |
| 133 | MAP3K11 | 0.33347163 |
| 134 | RPS6KA4 | 0.33089251 |
| 135 | MYLK | 0.33053189 |
| 136 | BUB1 | 0.32771481 |
| 137 | LIMK1 | 0.32200438 |
| 138 | ARAF | 0.31904301 |
| 139 | MARK2 | 0.31369330 |
| 140 | AKT2 | 0.31352484 |
| 141 | RPS6KC1 | 0.31257459 |
| 142 | RPS6KL1 | 0.31257459 |
| 143 | RPS6KA6 | 0.30450461 |
| 144 | MAPK1 | 0.30170468 |
| 145 | CDK9 | 0.30112245 |
| 146 | SRC | 0.29328913 |
| 147 | PDPK1 | 0.29259287 |
| 148 | STK38L | 0.27169823 |
| 149 | PRKAA1 | 0.26995840 |
| 150 | TIE1 | 0.26905666 |
| 151 | AURKB | 0.26494679 |
| 152 | CHEK1 | 0.26025879 |
| 153 | ADRBK1 | 0.25844413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.70227452 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.41802383 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.08695676 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.88518332 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.72090503 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62811047 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.57849447 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.55689239 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.53380699 |
| 10 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.36257606 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.11781068 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.09826017 |
| 13 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.99205079 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.98528007 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.95199126 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.92918139 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.91912691 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.90186330 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.88834499 |
| 20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.80304287 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.79890507 |
| 22 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.79817233 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.78737700 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.75432419 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64571859 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.59762774 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.58765643 |
| 28 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.54987286 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.54940417 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.54855793 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.51858943 |
| 32 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.51774384 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.51359418 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50903184 |
| 35 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.49553787 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.44398879 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.43790120 |
| 38 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.41727366 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.37125511 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.36829033 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.35563958 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.34484127 |
| 43 | * Bile secretion_Homo sapiens_hsa04976 | 1.33225134 |
| 44 | * Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.32128382 |
| 45 | Retinol metabolism_Homo sapiens_hsa00830 | 1.30418648 |
| 46 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.29156351 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23795374 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.22506358 |
| 49 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.21915029 |
| 50 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.18992843 |
| 51 | Thyroid cancer_Homo sapiens_hsa05216 | 1.18136850 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.17466579 |
| 53 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.08061476 |
| 54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.07851566 |
| 55 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.05093961 |
| 56 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.04784673 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01476813 |
| 58 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.00332866 |
| 59 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.98534969 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97192770 |
| 61 | Tight junction_Homo sapiens_hsa04530 | 0.96887054 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.96608573 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.96295216 |
| 64 | Axon guidance_Homo sapiens_hsa04360 | 0.94605405 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.92869034 |
| 66 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.90793439 |
| 67 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89324244 |
| 68 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.86774863 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83800332 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82211101 |
| 71 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.81299079 |
| 72 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.81145927 |
| 73 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.80598835 |
| 74 | Prostate cancer_Homo sapiens_hsa05215 | 0.79228492 |
| 75 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.79157694 |
| 76 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79130312 |
| 77 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.78580316 |
| 78 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.75897462 |
| 79 | Pathways in cancer_Homo sapiens_hsa05200 | 0.75686115 |
| 80 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.74193252 |
| 81 | Carbon metabolism_Homo sapiens_hsa01200 | 0.73300498 |
| 82 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.72821807 |
| 83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.72812631 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68425250 |
| 85 | Other glycan degradation_Homo sapiens_hsa00511 | 0.68208955 |
| 86 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67316304 |
| 87 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.67304972 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.65598911 |
| 89 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64683080 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62418252 |
| 91 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.62209265 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.62185875 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61939251 |
| 94 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61419642 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60482150 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59754389 |
| 97 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57915119 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.55844621 |
| 99 | Cell cycle_Homo sapiens_hsa04110 | 0.54526471 |
| 100 | Lysosome_Homo sapiens_hsa04142 | 0.53879539 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53146881 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52709365 |
| 103 | Bladder cancer_Homo sapiens_hsa05219 | 0.50688549 |
| 104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49601317 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49472964 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48486696 |
| 107 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48351920 |
| 108 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48215449 |
| 109 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.47968045 |
| 110 | Melanoma_Homo sapiens_hsa05218 | 0.46316558 |
| 111 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46237441 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | 0.44070247 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.42711110 |
| 114 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.42234883 |
| 115 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42054001 |
| 116 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.42041109 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41270880 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40500750 |
| 119 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40302513 |
| 120 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40279277 |
| 121 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39924144 |
| 122 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.38890293 |
| 123 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37810269 |
| 124 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.36812605 |
| 125 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.36412814 |
| 126 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34821920 |
| 127 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.33274274 |
| 128 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.32331999 |
| 129 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.28753086 |
| 130 | Malaria_Homo sapiens_hsa05144 | 0.28559966 |
| 131 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28137821 |
| 132 | Legionellosis_Homo sapiens_hsa05134 | 0.24693279 |
| 133 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24490130 |
| 134 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.24255334 |
| 135 | Pertussis_Homo sapiens_hsa05133 | 0.21780149 |
| 136 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.21743655 |
| 137 | Focal adhesion_Homo sapiens_hsa04510 | 0.19652419 |
| 138 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.19131272 |
| 139 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.17941127 |
| 140 | Adherens junction_Homo sapiens_hsa04520 | 0.17800743 |
| 141 | Metabolic pathways_Homo sapiens_hsa01100 | 0.17621643 |
| 142 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.17349297 |
| 143 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.15855305 |
| 144 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.14050417 |
| 145 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.13619999 |
| 146 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.13407078 |
| 147 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.13338118 |
| 148 | Leishmaniasis_Homo sapiens_hsa05140 | 0.12165809 |
| 149 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.11217792 |
| 150 | * Hepatitis C_Homo sapiens_hsa05160 | 0.10186227 |
| 151 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.09374849 |

